February 6, 2013
Cardiva Medical, Inc. Announces FDA Approval for VASCADE™ Vascular Closure System
September 25, 2012
Cardiva Medical, Inc. announces that it has obtained approval to apply the European CE Mark to its VASCADE™ Vascular Closure System (VCS)
August 9, 2012
Cardiva Medical, Inc. Completes Third Tranche of Series 2 Private Equity Financing.
August 2, 2012
Cardiva Medical submits final PMA module to FDA for VASCADE™ Vascular Closure System.
June 20, 2012
Cardiva Medical, Inc. Announces Completion of Enrollment in the RESPECT Clinical Trial Aimed at Demonstrating the Safety and Efficacy of the VASCADE Vascular Closure System.
April 25, 2011
Cardiva Medical, Inc. Completes First Tranche of Series 2 Private Equity Financing.
June 14, 2010
Cardiva Medical, Inc. Announces Appointment of Charles Maroney, President and Chief Executive Officer.
May 18, 2009
Cardiva Medical, Inc. Receives FDA Clearance for the Catalyst™ III System
©2013 Cardiva Medical, Inc.